Compare CTSO & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | MNDO |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9M | 20.6M |
| IPO Year | 2008 | 2000 |
| Metric | CTSO | MNDO |
|---|---|---|
| Price | $6.41 | $1.03 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 392.3K | 48.0K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 20.95% |
| EPS Growth | ★ 65.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $10.34 | N/A |
| Revenue Next Year | $22.41 | N/A |
| P/E Ratio | ★ N/A | $8.57 |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.30 | $0.85 |
| 52 Week High | $7.44 | $1.29 |
| Indicator | CTSO | MNDO |
|---|---|---|
| Relative Strength Index (RSI) | 90.86 | 46.42 |
| Support Level | $0.48 | $0.98 |
| Resistance Level | N/A | $1.08 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | 0.72 | -0.00 |
| Stochastic Oscillator | 85.76 | 37.16 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.